ArticleAmerican journal of preventive medicine2017
State-Level Awareness of Chronic Kidney Disease in the U.S.
Article in American journal of preventive medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
32 citing papers in PubMed, 50 citations in OpenAlex.
- Awareness and Discussions About Chronic Kidney Disease Among African-Americans with Chronic Kidney Disease and Hypertension: a Mixed Methods Study.Journal of general internal medicine · 2020Trial
- Estimating heterogeneous treatment effects with survival outcomes via a deep survival learner.Lifetime data analysis · 2026Article
- A genetic and clinical risk factor algorithm to aid in identifying new cases of chronic kidney disease from the general population.Frontiers in genetics · 2026Article
- Trends and Independent Correlates of Chronic Kidney Disease Awareness in US Adults: NHANES 1999-2020.American journal of nephrology · 2026Article
- Preventing chronic kidney disease and maintaining kidney health: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.Kidney international · 2025Article
- Guideline-Recommended Disease-Modifying Therapies for Patients with Cardiorenal Disease: A Call-to-Action Narrative Review.Advances in therapy · 2025Review
- Article
- Screening, identifying, and treating chronic kidney disease: why, who, when, how, and what?BMC nephrology · 2024Review
- Association of serum 25-hydroxyvitamin D with cardiovascular and all-cause mortality in patients with chronic kidney disease: NHANES 2007‒2018 results.Clinics (Sao Paulo, Brazil) · 2024Article
- Glycemic index of a nutritional supplement designed for people with chronic kidney disease.Food science & nutrition · 2023Article
- Deep learning-based electrocardiographic screening for chronic kidney disease.Communications medicine · 2023Article
- Chronic kidney disease unawareness and determinants using 1999-2014 National Health and Nutrition Examination Survey Data.Journal of public health (Oxford, England) · 2022Article
- Assessment of primary care physicians' knowledge of chronic kidney disease in Poland.Frontiers in public health · 2022Article
- Comparison of trend in chronic kidney disease burden between China, Japan, the United Kingdom, and the United States.Frontiers in public health · 2022Article
- Prevalence, recognition and management of chronic kidney disease in Japan: population-based estimate using a healthcare database with routine health checkup data.Clinical kidney journal · 2021Article
- Estimating tubular damage for predicting progression of chronic kidney disease-what are the implications for clinical practice and public health?Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2021Article
- Chronic Kidney Disease Testing Among At-Risk Adults in the U.S. Remains Low: Real-World Evidence From a National Laboratory Database.Diabetes care · 2021Article
- Medical records-based chronic kidney disease phenotype for clinical care and "big data" observational and genetic studies.NPJ digital medicine · 2021Article
- Similarity-based health risk prediction using Domain Fusion and electronic health records data.Journal of biomedical informatics · 2021Article
- Factors Associated With Physician Recommendation of Home Blood Pressure Monitoring and Blood Pressure in the US Population.American journal of hypertension · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors at 3 institutions in 1 country.
Funding
Abstract
introductionThis study examined state-level variation in chronic kidney disease (CKD) awareness using national estimates of disease awareness among adults in the U.S. with CKD.
methodsData on U.S. adults were obtained from two national, population-based surveys: (1) the Behavioral Risk Factor Surveillance System (BRFSS 2011; n=506,467), a state-level phone survey containing information on self-reported kidney disease; and (2) the National Health and Nutrition Examination Survey (NHANES 2005-2012; n=20,831), containing physical health examination, surveys containing data on self-reported kidney disease, risk factors, and laboratory values. CKD was defined as an estimated glomerular filtration rate of 15-59 mL/minute/1.73 m
resultsOverall, estimated CKD awareness was 9.0% (95% CI=8.0%, 10.0%), ranging from 5.8% (95% CI=4.8%, 6.8%) in Iowa to 11.7% (95% CI=9.7%, 13.7%) in Arizona. Awareness was greater among adults with hypertension (12.0%) and diabetes (15.3%) than among adults without those conditions, and lower in Hispanics (6.0%) than in non-Hispanic whites (8.8%), non-Hispanic blacks (9.9%), and other racial/ethnic groups (12.7%).
conclusionsAmong individuals with CKD, awareness of their condition was very low and varied approximately twofold among states. This is the first study to estimate awareness of kidney disease by state for the U.S. adult population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.